Sermorelin care · field notes
Who was studied?
What actually changed?
Start with who took part in the research. Then ask what was measured. Those details often answer more than a confident treatment claim does.
The children in the main growth study made too little growth hormone, a chemical message from the body, and were not growing normally.
Explore the field notes
What evidence supports adult use?
Why this matters
Ask whether the study included people like you and lasted long enough to answer your question. Take those questions to the doctor or other medical professional treating you.
| The question | Children with a hormone shortage | Small studies in older adults |
|---|---|---|
| The question | Could treatment improve growth? | Could the hormone response change? |
| The record | The main growth study enrolled 110 children; the published growth results covered 86 of them. | The older-adult studies had 10 to 19 people and lasted from 2 to 16 weeks. |
| The result | In the main children’s study, growth increased, but there was no separate group of children for comparison. | Hormone levels in the blood rose in some studies, while studies measuring body fat found no change. |
The recorded study information does not explain why some children were left out of the growth results. Ask about that before using the study to judge a treatment.
The studies did not all use sermorelin
One older-adult study used a medicine similar to sermorelin, with a small change in one of its chemical parts.
That study lasted 16 weeks and found no change in reported sleep quality.
Other sleep-lab studies used the brain’s natural hormone message that tells the body to release growth hormone, rather than sermorelin.
It was given into a vein, and the improvement in sleep was smaller in older people than in young men.
Before applying a study to your care, check which medicine was used and how it was given.
Results from a different medicine or an injection into a vein do not establish benefits from pharmacy-made sermorelin.
Read an approval claim in context
As of September 2026, the historical approvals were for testing hormone release and treating growth failure in children with a hormone shortage.
They did not cover adult energy, sleep, body shape or ageing.
The US drug regulator’s later finding about why sermorelin (Geref) left the market was not an endorsement of current products.
Use separate questions for separate claims: what was approved, what may be prepared now and what evidence supports your proposed goal.
Questions to ask about a study
- Were the people in the study like me?
- Did people receive sermorelin itself or a different medicine?
- Did the study measure my goal, or just a hormone level?
- Was there a group for comparison?
- How much does a short study leave unanswered?
Keep a question for later
On this deviceNotes stay in this browser. Nothing is sent to a clinic or to this guide.
Ready when you are.
Your saved questions will appear here.